As of 2020, ** percent of India's insulin market is controlled by multinational corporations. The biosimilars market, on the other hand, is overwhelmingly controlled by domestic pharmaceutical companies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EY. (February 22, 2021). Breakdown of insulin and biosimilars market in India in 2020, by foreign and domestic firms [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 04, 2026, from /statistics/1239106/india-insulin-and-biosimilars-market-share-by-foreign-and-domestic-firms/
EY. "Breakdown of insulin and biosimilars market in India in 2020, by foreign and domestic firms." Chart. February 22, 2021. ÌÇÐÄÆƽâ°æ. Accessed August 04, 2026. /statistics/1239106/india-insulin-and-biosimilars-market-share-by-foreign-and-domestic-firms/
EY. (2021). Breakdown of insulin and biosimilars market in India in 2020, by foreign and domestic firms. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 04, 2026. /statistics/1239106/india-insulin-and-biosimilars-market-share-by-foreign-and-domestic-firms/
EY. "Breakdown of Insulin and Biosimilars Market in India in 2020, by Foreign and Domestic Firms." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 22 Feb 2021, /statistics/1239106/india-insulin-and-biosimilars-market-share-by-foreign-and-domestic-firms/
EY, Breakdown of insulin and biosimilars market in India in 2020, by foreign and domestic firms ÌÇÐÄÆƽâ°æ, /statistics/1239106/india-insulin-and-biosimilars-market-share-by-foreign-and-domestic-firms/ (last visited August 04, 2026)
Breakdown of insulin and biosimilars market in India in 2020, by foreign and domestic firms [Graph], EY, February 22, 2021. [Online]. Available: /statistics/1239106/india-insulin-and-biosimilars-market-share-by-foreign-and-domestic-firms/
